Understanding of the mechanisms by which Pex11a deficiency decreased energy expenditure and fatty acid oxidation and resulted in the accumulation of very long‐ and long‐chain fatty acids will be required to develop therapeutic strategies for dyslipidaemia and obesity. The gene discussed is PEX11A; the disease is inherited lipid metabolism disorder.